Abstract:Nanoplastics-induced developmental and reproductive toxicity, neurotoxicity and immunotoxicity are a focus of widespread attention. However, the effects of nanoplastics (NPs) on glycolipid metabolism and the precise underlying mechanisms are unclear at present. Here, we showed that oral administration of polystyrene nanoparticles (PS-NPs) disrupts glycolipid metabolism, with reactive oxygen species (ROS) identified as a potential key signaling molecule. After PS-NPs treatment, excessive production of ROS induced the inflammatory response and activated the antioxidant pathway through nuclear factor-erythroid factor 2-related factor 2. The activation of nuclear factor-κB (NFκB) signaling pathway induced the phosphorylation of the mitogen-activated protein kinases (MAPK) signaling pathway, which induced the activation of extracellular regulated kinases (ERK) and p38. Constitutive activation of the MAPK signaling proteins induced high continued phosphorylation of insulin receptor substrate-1, in turn, leading to decreased protein kinase B (Akt) activity, which weakened the sensitivity of liver cells to insulin signals and induced insulin resistance. In parallel, phosphorylation of Akt led to loss of control of FoXO1, a key gene of gluconeogenesis, activating transcription of glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (PEPCK) in a manner dependent on PGC1α. Moreover, the activated ERK promoted lipid accumulation through ERK-PPARγ cascades. Therefore, sterol regulatory element-binding protein-1 and levels of its downstream lipogenic enzymes, ACC-1, were up-regulated. Upon treatment with the antioxidant resveratrol, PS-NPs-induced glucose and lipid metabolic disorders were improved by inhibiting ROS-induced activation of NFκB and MAPK signaling pathway in mice. Based on above, PS-NPs exposure disrupts glycolipid metabolism in mice, with ROS identified as a potential key signaling molecule.

What problem does this paper attempt to address?

The problem this paper attempts to address is the impact of polystyrene nanoplastics (PS-NPs) on glucose and lipid metabolism in mice and its potential mechanisms. Specifically, the researchers focus on how PS-NPs cause glucose and lipid metabolism disorders through the NF-κB and MAPK signaling pathways and explore whether the antioxidant resveratrol can improve the metabolic disturbances caused by PS-NPs. ### Research Background With the widespread use of plastic products, a large amount of plastic waste has been generated in the environment. These plastics further decompose into microplastics (MPs, size ≤ 5 mm) and nanoplastics (NPs, size ≤ 1 μm) under the effects of UV radiation, oxidation, weathering, and biodegradation. These tiny particles can enter animals and humans through the food chain or ingestion of contaminated food, leading to varying degrees of exposure. Studies have shown that nanoplastics can cause toxicological effects such as cytotoxicity, inflammatory responses, and oxidative stress, but their specific impact and mechanisms on glucose and lipid metabolism are still unclear. ### Research Objectives 1. **To explore the impact of PS-NPs on glucose and lipid metabolism in mice**: By oral administration, observe the effects of PS-NPs on blood glucose and lipid levels in mice. 2. **To reveal the molecular mechanisms of PS-NPs-induced glucose and lipid metabolism disorders**: Focus on the role of ROS (reactive oxygen species) in this process and the activation of NF-κB and MAPK signaling pathways. 3. **To evaluate the protective effect of the antioxidant resveratrol**: Investigate whether resveratrol can alleviate the metabolic disturbances caused by PS-NPs by inhibiting the production of ROS. ### Main Findings 1. **PS-NPs increase blood glucose levels in mice**: Experimental results show that after PS-NPs treatment, the blood glucose levels in mice significantly increased. The oral glucose tolerance test (OGTT) also indicated that the blood glucose peak in the PS-NPs treatment group was higher, and the recovery time was longer. 2. **PS-NPs affect lipid metabolism**: The levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDLC), and high-density lipoprotein cholesterol (HDLC) in the serum and liver of mice in the PS-NPs treatment group changed significantly. 3. **The role of ROS in metabolic disorders**: After PS-NPs treatment, the ROS levels in mice significantly increased, which may affect glucose and lipid metabolism by activating the NF-κB and MAPK signaling pathways. 4. **The protective effect of resveratrol**: Resveratrol can significantly reduce the accumulation of ROS caused by PS-NPs, thereby improving blood glucose and lipid levels, and reducing inflammatory responses and oxidative stress. ### Conclusion This study reveals the molecular mechanisms by which PS-NPs cause glucose and lipid metabolism disorders in mice through ROS-mediated NF-κB and MAPK signaling pathways and confirms the potential of the antioxidant resveratrol in alleviating these metabolic disturbances. These findings provide important scientific evidence for assessing the health risks of nanoplastics in the environment to humans.

Polystyrene nanoplastics induce glycolipid metabolism disorder via NF-κB and MAPK signaling pathway in mice

Effects of oral administration of polystyrene nanoplastics on plasma glucose metabolism in mice

Polystyrene Nanoplastics Induce Lipid Metabolism Disorder by Activating the PERK-ATF4 Signaling Pathway in Mice

Exposure to polystyrene nanoplastics induces hepatotoxicity involving NRF2-NLRP3 signaling pathway in mice

Polystyrene nanoplastics induce profound metabolic shift in human cells as revealed by integrated proteomic and metabolomic analysis

Polystyrene nanoplastic exposure enhances LPS-induced lung inflammation in mice by inducing M1 polarization of macrophages via ROS/JAK/STAT signaling pathway

[The effect and mechanism of exposure to polystyrene nanoplastics on lipid metabolism in mice liver]

Polystyrene nanoplastics induce lipophagy via the AMPK/ULK1 pathway and block lipophagic flux leading to lipid accumulation in hepatocytes

The effect and a mechanistic evaluation of polystyrene nanoplastics on a mouse model of type 2 diabetes

Polystyrene nanoparticles induced mammalian intestine damage caused by blockage of BNIP3/NIX-mediated mitophagy and gut microbiota alteration

Polystyrene nanoplastics exacerbated lipopolysaccharide‐induced necroptosis and inflammation via the ROS/MAPK pathway in mice spleen

Intergenerational neurotoxicity of polystyrene nanoplastics in offspring mice is mediated by dysfunctional microbe-gut-brain axis

Polystyrene nanoplastics-induced lung apoptosis and ferroptosis via ROS-dependent endoplasmic reticulum stress

In situ profiling reveals spatially metabolic injury in the initiation of polystyrene nanoplastic-derived intestinal epithelial injury in mice

Polystyrene nanoplastics induce intestinal and hepatic inflammation through activation of NF-κB/NLRP3 pathways and related gut-liver axis in mice

Tissue distribution of polystyrene nanoplastics in mice and their entry, transport, and cytotoxicity to GES-1 cells

Effects of polystyrene nanoplastic gestational exposure on mice

Polystyrene nanoplastics inhibit beige fat function and exacerbate metabolic disorder in high-fat diet-fed mice

Polystyrene nanoplastics cause reproductive toxicity in zebrafish: PPAR mediated lipid metabolism disorder

Polystyrene nanobeads exacerbate chronic colitis in mice involving in oxidative stress and hepatic lipid metabolism

Polystyrene nanoplastics induced learning and memory impairments in mice by damaging the glymphatic system